9 CFR 113.100 - General requirements for inactivated bacterial products.
Unless otherwise prescribed in an applicable Standard Requirement or in the filed Outline of Production, an inactivated bacterial product shall meet the applicable requirements in this section.
(1) Final container samples of completed product from each serial and each subserial shall be tested for viable bacteria and fungi as provided in § 113.26.
(2) Each lot of Master Seed Bacteria shall be tested for the presence of extraneous viable bacteria and fungi in accordance with the test provided in § 113.27(d).
(b)Safety tests. Bulk or final container samples of completed product from each serial shall be tested for safety in young adult mice in accordance with the test provided in § 113.33(b) unless:
(3) The product is recommended for fish, other aquatic species, or reptiles. In such instances, the product shall be safety tested in fish, other aquatic species, or reptiles as required by specific Standard Requirement or Outline of Production for the product.
(c)Identity test. Methods of identification of Master Seed Bacteria to the genus and species level by laboratory tests shall be sufficient to distinguish the bacteria from other similar bacteria according to criteria described in the most recent edition of “Bergey's Manual of Systematic Bacteriology” or the American Society for Microbiology “Manual of Clinical Microbiology”. If Master Seed Bacteria are referred to by serotype, serovar, subtype, pilus type, strain or other taxonomic subdivision below the species level, adequate testing must be used to identify the bacteria to that level. Tests which may be used to identify Master Seed Bacteria include, but are not limited to:
(1) Cultural characteristics,
(2) Staining reaction,
(3) Biochemical reactivity,
(4) Fluorescent antibody tests,
(5) Serologic tests,
(6) Toxin typing,
(7) Somatic or flagellar antigen characterization, and
(8) Restriction endonuclease analysis.
(d)Ingredient requirements. Ingredients used for the growth and preparation of Master Seed Bacteria and of final product shall meet the requirements provided in § 113.50. Ingredients of animal origin shall meet the applicable requirements provided in § 113.53.
(e) Only serials tested for viricidal activity in accordance with the test provided in § 113.35 and found satisfactory by such test shall be packaged as diluent for desiccated fractions in combination packages.
(f) If formaldehyde is used as the inactivating agent, and the serial has not been found satisfactory by the viricidal activity test, bulk or final container samples of completed product from each serial must be tested for residual free formaldehyde content using the ferric chloride test. 1 Firms currently using tests for residual free formaldehyde content other than the ferric chloride test have until July 14, 2004 to update their Outline of Production to be in compliance with this requirement.
1 The procedures for performing the ferric chloride test for residual free formaldehyde may be obtained from USDA, APHIS, Center for Veterinary Biologics-Laboratory, 1800 Dayton Road, P.O. Box 844, Ames, IA 50010.
(1) The residual free formaldehyde content of biological products containing clostridial antigens must not exceed 1.85 grams per liter (g/L).
(2) The residual free formaldehyde content of bacterins, bacterin-toxoids, and toxoids, other than those containing clostridial antigens, must not exceed 0.74 grams per liter (g/L).
Title 9 published on 14-Sep-2017 03:43
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 9 CFR Part 113 after this date.
- 9 CFR 113.116 — Pasteurella Multocida Bacterin, Avian Isolate, Type 4.
- 9 CFR 113.113 — Autogenous Biologics.
- 9 CFR 113.119 — Erysipelothrix Rhusiopathiae Bacterin.
- 9 CFR 113.7 — Multiple Fractions.
- 9 CFR 113.117 — Pasteurella Multocida Bacterin, Avian Isolate, Type 1.
- 9 CFR 113.110 — Clostridium Botulinum Type C Bacterin-Toxoid.
- 9 CFR 113.105 — Leptospira Hardjo Bacterin.
- 9 CFR 113.101 — Leptospira Pomona Bacterin.
- 9 CFR 113.112 — Clostridium Perfringens Type D Toxoid and Bacterin-Toxoid.
- 9 CFR 113.121 — Pasteurella Multocida Bacterin.
- 9 CFR 113.114 — Tetanus Toxoid.
- 9 CFR 113.108 — Clostridium Novyi Bacterin-Toxoid.
- 9 CFR 113.106 — Clostridium Chauvoei Bacterin.
- 9 CFR 113.102 — Leptospira Icterohaemorrhagiae Bacterin.
- 9 CFR 113.107 — Clostridium Haemolyticum Bacterin.
- 9 CFR 113.120 — Salmonella Typhimurium Bacterin.
- 9 CFR 113.103 — Leptospira Canicola Bacterin.
- 9 CFR 113.115 — Staphylococcus Aureus Bacterin-Toxoid.
- 9 CFR 113.109 — Clostridium Sordellii Bacterin-Toxoid.
- 9 CFR 113.104 — Leptospira Grippotyphosa Bacterin.
- 9 CFR 113.111 — Clostridium Perfringens Type C Toxoid and Bacterin-Toxoid.
- 9 CFR 113.118 — Pasteurella Multocida Bacterin, Avian Isolate, Type 3.